Hiroyuki Orita

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

Wasaburo Koizumi, Hiroyuki Narahara, Takuo Hara et al. · The Lancet Oncology · 2008 · 1.9K citations

Surgical Oncology, Spirits Trial, Gastrointestinal Oncology +8

Risk factors associated with surgical site infection in upper and lower gastrointestinal surgery

Akihiro Watanabe, Shunji Kohnoe, Rinshun Shimabukuro et al. · Surgery Today · 2008 · 178 citations

Surgical Site Infections, Surgical Quality Control, Clinical Epidemiology +11

Signet ring cell carcinoma of the stomach

Yoshihiko Maehara, Yoshihisa Sakaguchi, Sunao Moriguchi et al. · Cancer · 1992 · 139 citations · Full text

Overexpression of Hypoxia-Inducible Factor 1α and p53 Is a Marker for an Unfavorable Prognosis in Gastric Cancer

Yasushi Sumiyoshi, Yoshihiro Kakeji, Akinori Egashira et al. · Clinical Cancer Research · 2006 · 99 citations

Association between cardiometabolic index and atherosclerotic progression in patients with peripheral arterial disease

Ichiro Wakabayashi, Yoko Sotoda, Shigeki Hirooka et al. · Clinica Chimica Acta · 2015 · 94 citations

Vascular Disease, Cardiovascular Epidemiology, Cardiovascular Disease +11